切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (05) : 625 -628. doi: 10.3877/cma.j.issn.2095-3232.2024.05.006

专家论坛

胰头癌淋巴结清扫再思考
郭诗翔1, 谭明达1, 王槐志1,()   
  1. 1. 400016 重庆医科大学;400714 中国科学院重庆绿色智能技术研究院;400714 中国科学院大学重庆学院;401147 重庆市人民医院肝胆胰腺外科研究所
  • 收稿日期:2024-05-15 出版日期:2024-10-10
  • 通信作者: 王槐志
  • 基金资助:
    国家自然科学基金(82373128); 重庆英才计划-青年拔尖人才"包干制"项目(cstc2022ycjh-bgzxm0137); 重庆市渝中区自然科学基金(20210160); 重庆市科卫联合医学科研项目(2024MSXM174)

Rethinking lymph node dissection in pancreatic head cancer

Shixiang Guo1, Mingda Tan1, Huaizhi Wang1,()   

  1. 1. Chongqing Medical University, Chongqing 400016, China; Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400714, China; Chongqing School, University of Chinese Academy of Sciences, Chongqing 400714, China; Institute of Hepatobiliary and Pancreatic Surgery, Chongqing General Hospital, Chongqing 401147, China
  • Received:2024-05-15 Published:2024-10-10
  • Corresponding author: Huaizhi Wang
引用本文:

郭诗翔, 谭明达, 王槐志. 胰头癌淋巴结清扫再思考[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 625-628.

Shixiang Guo, Mingda Tan, Huaizhi Wang. Rethinking lymph node dissection in pancreatic head cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 625-628.

胰腺癌是一种高致死率的消化道恶性肿瘤,起病隐匿,因缺乏早期高敏度特异性诊断标志物,大部分患者就诊时已处于中晚期,根治性手术切除率低,预后极差,5年生存率低于10%。根治性切除术是治愈胰腺癌的唯一有效途径,由于其恶性程度高且具有高度嗜神经性,早期极易发生原位复发、区域淋巴结或远处转移,故淋巴结清扫的彻底性对于患者远期疗效及预后尤为重要。随着现代外科的不断发展,各中心不同胰腺外科医师对于胰头癌淋巴结清扫内涵理解不同,相关研究存在明显的异质性。本文结合目前国内外研究进展及本中心临床实践,详述胰头癌淋巴结清扫在胰腺癌中的应用。

Pancreatic cancer is a malignant digestive tract tumor with high mortality and hidden onset. Due to the lack of early high-sensitivity specific diagnostic markers, most patients are diagnosed in the middle and late stage. Radical resection rate is low, clinical prognosis is extremely poor, and the 5-year survival rate is less than 10%. Radical resection is the only effective treatment for pancreatic cancer. Because of high-degree malignancy and high-degree neurophilia, the risk of local recurrence, regional lymph node or distant metastases is high in the early stage. Hence, the completeness of lymph node dissection plays a significant role in the long-term efficacy and prognosis of patients. With persistent development of modern surgery, pancreatic cancer surgeons from different centers have different understandings of the connotation of lymph node dissection for pancreatic head cancer, and relevant studies yield high heterogeneity. Based on the latest research progress at home and abroad and clinical practice of our center, the application of lymph node dissection of pancreatic head cancer in pancreatic cancer was explicitly illustrated in this article.

[1]
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA A Cancer J Clin, 2022, 72(1):7-33.
[2]
Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment[J]. Technol Cancer Res Treat, 2020, 19: 1533033820962117.
[3]
Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis[J]. Cancer Lett, 2021, 520:1-11.
[4]
Tempero MA. NCCN guidelines updates: pancreatic cancer[J]. J Natl Compr Canc Netw, 2019, 17(5.5):603-605.
[5]
Masiak-Segit W, Rawicz-Pruszyński K, Skórzewska M, et al. Surgical treatment of pancreatic cancer[J]. Pol Przegl Chir, 2018, 90(2):45-53.
[6]
Min SK, You Y, Choi DW, et al. Prognosis of pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(9):1004-1013.
[7]
Karunakaran M, Barreto SG. Surgery for pancreatic cancer: current controversies and challenges[J]. Future Oncol, 2021, 17(36):5135-5162.
[8]
Varshney VK. Pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(11):e116.
[9]
Arrington AK, Price ET, Golisch K, et al. Pancreatic cancer lymph node resection revisited: a novel calculation of number of lymph nodes required[J]. J Am Coll Surg, 2019, 228(4):662-669.
[10]
Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J]. Surgery, 2014, 156(3):591-600.
[11]
Ignjatovic I, Knezevic S, Knezevic D, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma[J]. J BUON, 2017, 22(1):232-238.
[12]
Pu N, Mu S, Fang Y, et al. Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study[J]. Transl Cancer Res, 2020, 9(3):1476-1486.
[13]
Lin Q, Zheng S, Yu X, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial[J]. Cancer Commun, 2023, 43(2):257-275.
[14]
Guo X, Song Y, Xu P, et al. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study[J]. Int J Surg, 2023, 109(7):1852-1862.
[15]
Wang Z, Ke N, Wang X, et al. Optimal extent of lymphadenectomy for radical surgery of pancreatic head adenocarcinoma: 2-year survival rate results of single-center, prospective, randomized controlled study[J]. Medicine, 2021, 100(35):e26918.
[16]
Imamura T, Yamamoto Y, Sugiura T, et al. Reconsidering the optimal regional lymph node station according to tumor location for pancreatic cancer[J]. Ann Surg Oncol, 2021, 28(3):1602-1611.
[17]
Qian L, Xie J, Xu Z, et al. The necessity of dissection of No. 14 lymph nodes to patients with pancreatic ductal adenocarcinoma based on the embryonic development of the head of the pancreas[J]. Front Oncol, 2020, 10: 1343.
[18]
Mirkin KA, Hollenbeak CS, Wong J. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer[J]. J Surg Res, 2017, 220: 12-24.
[19]
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6):1127-1143, e18.
[20]
杨尹默, 李宝毅, 马永蔌. 胰腺癌免疫治疗现状与进展[J]. 中华普通外科杂志, 2023, 38(5):321-325
[21]
Huang Q, Wu X, Wang Z, et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes[J]. Cell, 2022, 185(22):4049-4066, e25.
[1] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[2] 王若岩, 贾琳娇, 孔舒欣, 范盼红, 王磊, 李文涛. 原发性肺癌乳腺转移一例[J]. 中华乳腺病杂志(电子版), 2024, 18(04): 248-250.
[3] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[4] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 蔡永芹, 王君菊, 张敬敬. 不同下纵隔淋巴结清扫顺序在Siewert Ⅱ型食管胃结合部腺癌中应用效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 562-565.
[7] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[8] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[9] 张金华, 赵锁. 早期ICC腹腔镜肝切除术不同淋巴结清扫范围的近远期效果对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 578-581.
[10] 黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[11] 田文. 甲状腺癌功能性根治颈淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 482-482.
[12] 史成宇, 季晓琳, 田莉莹, 张来香. 腹腔镜胰十二指肠切除术中第14c/d组淋巴结清扫在胰头癌中的临床效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 430-433.
[13] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[14] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[15] 闫战涛, 王辉, 周梓迪, 史勇强, 陈铜兵. 胃淋巴上皮瘤样癌三级淋巴结构特征及其与预后的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 455-461.
阅读次数
全文


摘要